The Impact of Initial Vascular Access on Long-term Mortality in Hemodialysis Thai Patients

Kanin Thammavaranucupt; Chalothorn  Taesilapasathit; Supawadee Suppadungsuk; Napun Sutharattanapong; Kotcharat Vipattawat; Sethanant Sethakarun; Kulapong Jayanama; Ittikorn Spanuchart

doi:10.33165/rmj.2022.45.1.255572

Authors

Kanin Thammavaranucupt Chakri Naruebodindra Medical Institute, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Samut Prakan, Thailand
Chalothorn Taesilapasathit Chakri Naruebodindra Medical Institute, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Samut Prakan, Thailand
Supawadee Suppadungsuk Chakri Naruebodindra Medical Institute, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Samut Prakan, Thailand
Napun Sutharattanapong Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
Kotcharat Vipattawat Bhumirajanagarindra Kidney Institute Hospital, Bangkok, Thailand
Sethanant Sethakarun Bhumirajanagarindra Kidney Institute Hospital, Bangkok, Thailand
Kulapong Jayanama Chakri Naruebodindra Medical Institute, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Samut Prakan, Thailand
Ittikorn Spanuchart Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand

DOI:

https://doi.org/10.33165/rmj.2022.45.1.255572

Keywords:

Hemodialysis, Mortality, Tunneled dialysis catheter, Vascular access

Abstract

Background: End-stage kidney disease (ESKD) patients are significantly at risk of higher mortality than the general population. While cardiovascular disease and infection are the major causes of death in ESKD patients on hemodialysis (HD), the impact of vascular access type on long-term mortality in the Thai population remains unclear.

Objective: To find an association between types of vascular access and long-term mortality in HD Thai patients.

Methods: A multicenter, retrospective cohort of HD patients with a 55-month follow-up (November 2015 to December 2020) was conducted. Patients’ baseline characteristics, and HD profiles were reviewed. A logistic regression model and survival analysis were used to test the association and survival probability of each type of vascular access and mortality.

Results: Of 196 HD patients over 55 months, the proportions of initial vascular access included 46.94% of arteriovenous fistula (AVF), 27.55% of arteriovenous graft (AVG), and 25.51% of tunneled dialysis catheter (TDC). The overall mean all-cause mortality in this cohort was 29.1%. Compared with AVF, TDC was associated with increased mortality (adjusted OR, 3.18; 95% CI, 1.37 - 7.37; P < .05) while the association between AVG and mortality was borderline significant (adjusted OR, 2.29; 95% CI, 0.96 - 5.46; P > .05).

Conclusions: TDC as initial vascular access for incident HD Thai patients was associated with increased all-cause mortality at 55 months compared with functioning AVF.

References

Lv JC, Zhang LX. Prevalence and disease burden of chronic kidney disease. Adv Exp Med Biol. 2019;1165:3-15. doi:10.1007/978-981-13-8871-2_1

Stevens PE, Levin A; Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med. 2013;158(11):825-830. doi:10.7326/0003-4819-158-11-201306040-00007

Collins AJ, Foley RN, Herzog C, et al. Excerpts from the US renal data system 2009 annual data report. Am J Kidney Dis. 2010;55(1 Suppl 1):S1-A7. doi:10.1053/j.ajkd.2009.10.009

Bloembergen WE, Port FK, Mauger EA, Wolfe RA. Causes of death in dialysis patients: racial and gender differences. J Am Soc Nephrol. 1994;5(5):1231-1242. doi:10.1681/ASN.V551231

Dixon BS, Novak L, Fangman J. Hemodialysis vascular access survival: upper-arm native arteriovenous fistula. Am J Kidney Dis. 2002;39(1):92-101. doi:10.1053/ajkd.2002.29886

Perera GB, Mueller MP, Kubaska SM, Wilson SE, Lawrence PF, Fujitani RM. Superiority of autogenous arteriovenous hemodialysis access: maintenance of function with fewer secondary interventions. Ann Vasc Surg. 2004;18(1):66-73. doi:10.1007/s10016-003-0094-y

Keuter XH, De Smet AA, Kessels AG, van der Sande FM, Welten RJ, Tordoir JH. A randomized multicenter study of the outcome of brachial-basilic arteriovenous fistula and prosthetic brachial-antecubital forearm loop as vascular access for hemodialysis. J Vasc Surg. 2008;47(2):395-401. doi:10.1016/j.jvs.2007.09.063

Pisoni RL, Young EW, Dykstra DM, et al. Vascular access use in Europe and the United States: results from the DOPPS. Kidney Int. 2002;61(1):305-316. doi:10.1046/j.1523-1755.2002.00117.x

Lok CE, Allon M, Moist L, Oliver MJ, Shah H, Zimmerman D. Risk equation determining unsuccessful cannulation events and failure to maturation in arteriovenous fistulas (REDUCE FTM I). J Am Soc Nephrol. 2006;17(11):3204-3212. doi:10.1681/ASN.2006030190

Hamadneh SA, Nueirat SA, Qadoomi' J, Shurrab M, Qunibi WY, Hamdan Z. Vascular access mortality and hospitalization among hemodialysis patients in Palestine. Saudi J Kidney Dis Transpl. 2018;29(1):120-126. doi:10.4103/1319-2442.225184

Yeh LM, Chiu SY, Lai PC. The impact of vascular access types on hemodialysis patient long-term survival. Sci Rep. 2019;9(1):10708. doi:10.1038/s41598-019-47065-z

Celik S, Gok Oguz E, Ulusal Okyay G, Selen T, Ayli MD. The impact of arteriovenous fistulas and tunneled cuffed venous catheters on morbidity and mortality in hemodialysis patients: a single center experience. Int J Artif Organs. 2021;44(4):229-236. doi:10.1177/0391398820952808

Bray BD, Boyd J, Daly C, et al. Vascular access type and risk of mortality in a national prospective cohort of haemodialysis patients. QJM. 2012;105(11):1097-1103. doi:10.1093/qjmed/hcs143

Merport M, Murphy TP, Egglin TK, Dubel GJ. Fibrin sheath stripping versus catheter exchange for the treatment of failed tunneled hemodialysis catheters: randomized clinical trial. J Vasc Interv Radiol. 2000;11(9):1115-1120. doi:10.1016/s1051-0443(07)61351-7

Huijbregts HJ, Bots ML, Wittens CH, et al. Hemodialysis arteriovenous fistula patency revisited: results of a prospective, multicenter initiative. Clin J Am Soc Nephrol. 2008;3(3):714-719. doi:10.2215/CJN.02950707

Lok CE, Sontrop JM, Tomlinson G, et al. Cumulative patency of contemporary fistulas versus grafts (2000-2010). Clin J Am Soc Nephrol. 2013;8(5):810-818. doi:10.2215/CJN.00730112

Alomari AI, Falk A. The natural history of tunneled hemodialysis catheters removed or exchanged: a single-institution experience. J Vasc Interv Radiol. 2007;18(2):227-235. doi:10.1016/j.jvir.2006.12.719

Gray RJ, Levitin A, Buck D, et al. Percutaneous fibrin sheath stripping versus transcatheter urokinase infusion for malfunctioning well-positioned tunneled central venous dialysis catheters: a prospective, randomized trial. J Vasc Interv Radiol. 2000;11(9):1121-1129. doi:10.1016/s1051-0443(07)61352-9

Suhocki PV, Conlon PJ Jr, Knelson MH, Harland R, Schwab SJ. Silastic cuffed catheters for hemodialysis vascular access: thrombolytic and mechanical correction of malfunction. Am J Kidney Dis. 1996;28(3):379-386. doi:10.1016/s0272-6386(96)90495-3

Thapa S, Terry PB, Kamdar BB. Hemodialysis catheter-associated superior vena cava syndrome and pulmonary embolism: a case report and review of the literature. BMC Res Notes. 2016;9:233. doi:10.1186/s13104-016-2043-1

Allon M. Dialysis catheter-related bacteremia: treatment and prophylaxis. Am J Kidney Dis. 2004;44(5):779-791.

Taylor G, Gravel D, Johnston L, et al. Incidence of bloodstream infection in multicenter inception cohorts of hemodialysis patients. Am J Infect Control. 2004;32(3):155-160. doi:10.1016/j.ajic.2003.05.007

Hung A, Pupim L, Yu C, et al. Determinants of C-reactive protein in chronic hemodialysis patients: relevance of dialysis catheter utilization. Hemodial Int. 2008;12(2):236-243. doi:10.1111/j.1542-4758.2008.00260.x

Goldstein SL, Ikizler TA, Zappitelli M, Silverstein DM, Ayus JC. Non-infected hemodialysis catheters are associated with increased inflammation compared to arteriovenous fistulas. Kidney Int. 2009;76(10):1063-1069. doi:10.1038/ki.2009.303

Hung AM, Ikizler TA. Hemodialysis central venous catheters as a source of inflammation and its implications. Semin Dial. 2008;21(5):401-404. doi:10.1111/j.1525-139X.2008.00444.x

Ma L, Zhao S. Risk factors for mortality in patients undergoing hemodialysis: a systematic review and meta-analysis. Int J Cardiol. 2017;238:151-158. doi:10.1016/j.ijcard.2017.02.095

Ladhani M, Craig JC, Irving M, Clayton PA, Wong G. Obesity and the risk of cardiovascular and all-cause mortality in chronic kidney disease: a systematic review and meta-analysis. Nephrol Dial Transplant. 2017;32(3):439-449. doi:10.1093/ndt/gfw075

Caetano C, Valente A, Oliveira T, Garagarza C. Body composition and mortality predictors in hemodialysis patients. J Ren Nutr. 2016;26(2):81-86. doi:10.1053/j.jrn.2015.10.005

Stosovic MD, Naumovic RT, Stanojevic MLj, Simic-Ogrizovic SP, Jovanovic DB, Djukanovic LD. Could the level of serum albumin be a method for assessing malnutrition in hemodialysis patients? Nutr Clin Pract. 2011;26(5):607-613. doi:10.1177/0884533611419665

Haller C. Hypoalbuminemia in renal failure: pathogenesis and therapeutic considerations. Kidney Blood Press Res. 2005;28(5-6):307-310. doi:10.1159/000090185